A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Clinical trial NCT01318421 · TERMINATED

Trial details

NCT number: NCT01318421
Sponsor: Elan Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2010-12-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.